Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 246 Precursor Cell Lymphoblastic Leukemia-Lymphoma 147 Myelodysplastic Syndromes 144 Leukemia, Lymphocytic, Chronic, B-Cell 140 Leukemia 128 Multiple Myeloma 118 Lymphoma 116 Lymphoma, Non-Hodgkin 112 Recurrence 80 Hematologic Neoplasms 77 Melanoma 68 Hodgkin Disease 68 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 67 Lymphoma, B-Cell 61 Lymphoma, Mantle-Cell 52 Lymphoma, Large B-Cell, Diffuse 50 Lymphoma, Follicular 50 Burkitt Lymphoma 41 Ovarian Neoplasms 40 Neoplasms 39 Myeloproliferative Disorders 39 Neoplasm Metastasis 34 Lymphoma, B-Cell, Marginal Zone 30 Graft vs Host Disease 29 Neoplasms, Plasma Cell 28 Carcinoma, Non-Small-Cell Lung 27 Breast Neoplasms 27 Leukemia, Biphenotypic, Acute 25 Primary Myelofibrosis 24 Anemia, Refractory, with Excess of Blasts 23

Interventions

Carboplatin 71 Paclitaxel 49 Radiotherapy 44 Pemetrexed 42 Cisplatin 41 Bevacizumab 39 Gemcitabine 27 Docetaxel 27 Erlotinib Hydrochloride 23 Gefitinib 18 pembrolizumab 14 Taxes 13 Vinorelbine 10 Cetuximab 10 Radiation 8 Nivolumab 8 Magnetic Resonance Spectroscopy 8 capmatinib 7 Radiosurgery 7 Platinum 7 Etoposide 7 Surgical Procedures, Operative 6 Radiotherapy, Conformal 6 Mastectomy, Segmental 6 ceritinib 5 aflutinib 5 Specimen Handling 5 Neoadjuvant Therapy 5 Cyclophosphamide 5 Biopsy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × fludarabine × Clear all

NCT05566223 2026-02-23

CheckCell-2

Intima Bioscience, Inc.

Phase 1/2 Withdrawn

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡